We are live on ! Find out more
TMBR

Timber Pharmaceuticals, Inc.
TMBR

Delisted

TMBR was delisted on the 28th of November, 2023.

Back to rankings

17 hedge funds and large institutions have $2.63M invested in Timber Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less funds holding

Funds holding: 20 → 17 (-3)

17% less capital invested

Capital invested by funds: $3.19M → $2.63M (-$557K)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$136K
2
Citadel Advisors
Citadel Advisors
Florida
+$45.4K
3
UBS Group
UBS Group
Switzerland
+$4.86K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$59K
2
Renaissance Technologies
Renaissance Technologies
New York
-$59K
3
LFAS
Level Four Advisory Services
Texas
-$7K
4
TSS
Two Sigma Securities
New York
-$6.49K
5
VF
Virtu Financial
New York
-$6.49K
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Vivo Capital
California
$1.42M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$669K +$136K +84 +20%
Franklin Resources
3
Franklin Resources
California
$403K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$59K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$36K +$45.4K +28 New
TSS
6
Two Sigma Securities
New York
$12K -$6.49K -4 -31%
Northern Trust
7
Northern Trust
Illinois
$8K – – –
VF
8
Virtu Financial
New York
$4K -$6.49K -4 -57%
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$4K – – –
LPL Financial
10
LPL Financial
California
$4K – – –
FFWA
11
FRG Family Wealth Advisors
Washington
$3K – – –
HF
12
HRT Financial
New York
$3K – – –
OC
13
Oppenheimer & Co
New York
$3K – – –
UBS Group
14
UBS Group
Switzerland
$3K +$4.86K +3 New
CPIG
15
Chicago Partners Investment Group
Illinois
$2K – – –
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$1K -$3.24K -2 -67%
BlackRock
17
BlackRock
New York
$1K – – –
CB
18
Commerce Bank
Missouri
$1K – – –
Deutsche Bank
19
Deutsche Bank
Germany
– -$59K -37 Closed
Renaissance Technologies
20
Renaissance Technologies
New York
– -$59K -37 Closed
LFAS
21
Level Four Advisory Services
Texas
– -$7K -4 Closed
Invesco
22
Invesco
Georgia
– -$5K -3 Closed
Millennium Management
23
Millennium Management
New York
– -$3K -2 Closed

TMBR Hedge Fund Activity: Q1 2019 in Review

17 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q1 2019, worth a combined $2.63M — down 17% from $3.19M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TMBR and 2 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $136K. The largest seller was Deutsche Bank, exiting entirely with an estimated $59K sold.

  • 17 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q1 2019, down from 20 in Q4 2018.
  • Funds reported $2.63M of Timber Pharmaceuticals, Inc. stock for Q1 2019, down 17% quarter-over-quarter.
  • 2 funds opened new Timber Pharmaceuticals, Inc. positions in Q1 2019 and 5 closed out, a net change of -3 holders.
  • The largest Timber Pharmaceuticals, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $136K added.
  • The largest Timber Pharmaceuticals, Inc. seller in Q1 2019 was Deutsche Bank, an estimated $59K sold.

Based on aggregated 13F filings for Q1 2019.